Evogene (EVGN) Retained Earnings (2012 - 2025)

Evogene has disclosed Retained Earnings across 14 years of filings, most recently posting -$282.6 million for Q4 2025.

• In Q4 2025, Retained Earnings fell 3.1% year-over-year to -$282.6 million; the TTM figure through Dec 2025 stood at -$282.6 million (down 3.1% YoY), while the FY2025 annual figure was -$282.6 million, down 3.1% from the prior year.
• Retained Earnings came in at -$282.6 million for Q4 2025 at Evogene, down from -$281.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$185.9 million in Q1 2021 to a low of -$282.6 million in Q4 2025.
• Average Retained Earnings over 5 years is -$240.3 million, with a median of -$243.5 million recorded in 2023.
• Year-over-year, Retained Earnings declined 16.7% in 2022 and dropped 3.1% in 2025.
• Over 5 years, Retained Earnings stood at -$207.1 million in 2021, then decreased by 12.86% to -$233.7 million in 2022, then fell by 10.22% to -$257.6 million in 2023, then slipped by 6.4% to -$274.1 million in 2024, then fell by 3.1% to -$282.6 million in 2025.
• Per Business Quant data, the three most recent Retained Earnings figures were -$282.6 million in Q4 2025, -$281.1 million in Q2 2025, and -$274.1 million in Q4 2024.